Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe. Issue 1 (5th January 2021)

• Record Type: Journal Article
• Authors: Valverde, Israel; Singh, Yogen; Sanchez-de-Toledo, Joan; Theocharis, Paraskevi; Chikermane, Ashish; Di Filippo, Sylvie; Kuciñska, Beata; Mannarino, Savina; Tamariz-Martel, Amalia; Gutierrez-Larraya, Federico; Soda, Giridhar; Vandekerckhove, Kristof; Gonzalez-Barlatay, Francisco; McMahon, Colin Joseph; Marcora, Simona; Napoleone, Carlo Pace; Duong, Phuoc; Tuo, Giulia; Deri, Antigoni; Nepali, Gauri; Ilina, Maria; Ciliberti, Paolo; Miller, Owen
• Is Part Of: Circulation. Volume 143:Issue 1(2021)
• Publication Date: 2021-01-05
• Subjects: cardiology -- cardiovascular diseases -- COVID-19 -- pandemics -- pediatric multisystem inflammatory disease, COVID-19 related; Blood -- Circulation -- Periodicals; Cardiovascular system -- Periodicals; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; Blood Circulation; Cardiovascular System; Vascular Diseases; 616.1
• DOI: 10.1161/CIRCULATIONAHA.120.050065
• Languages: English
• ISSNs: 0009-7322

Abstract

Abstract : Background: The aim of the study was to document cardiovascular clinical findings, cardiac imaging, and laboratory markers in children presenting with the novel multisystem inflammatory syndrome associated with coronavirus disease 2019 (COVID-19) infection. Methods: This real-time internet-based survey has been endorsed by the Association for European Paediatric and Congenital Cardiologists Working Groups for Cardiac Imaging and Cardiovascular Intensive Care. Children 0 to 18 years of age admitted to a hospital between February 1 and June 6, 2020, with a diagnosis of an inflammatory syndrome and acute cardiovascular complications were included. Results: A total of 286 children from 55 centers in 17 European countries were included. The median age was 8.4 years (interquartile range, 3.8–12.4 years) and 67% were boys. The most common cardiovascular complications were shock, cardiac arrhythmias, pericardial effusion, and coronary artery dilatation. Reduced left ventricular ejection fraction was present in over half of the patients, and a vast majority of children had raised cardiac troponin when checked. The biochemical markers of inflammation were raised in most patients on admission: elevated C-reactive protein, serum ferritin, procalcitonin, N-terminal pro B-type natriuretic peptide, interleukin-6 level, and D-dimers. There was a statistically significant correlation between degree of elevation in cardiac and biochemical parameters and the need for intensive care support ( P <0.05). Polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 was positive in 33.6%, whereas immunoglobulin M and immunoglobulin G antibodies were positive in 15.7% cases and immunoglobulin G in 43.6% cases, respectively, when checked. One child in the study cohort died. Conclusions: Cardiac involvement is common in children with multisystem inflammatory syndrome associated with the Covid-19 pandemic. The majority of children have significantly raised levels of N-terminal pro B-type natriuretic peptide, ferritin, D-dimers, and cardiac troponin in addition to high C-reactive protein and procalcitonin levels. In comparison with adults with COVID-19, mortality in children with multisystem inflammatory syndrome associated with COVID-19 is uncommon despite multisystem involvement, very elevated inflammatory markers, and the need for intensive care support. Abstract : Supplemental Digital Content is available in the text.